Email this article 
Hide
Show all
Case Report
Control and non-progression of HIV-1 infection in sub-Saharan Africa: A case and review
Southern African Journal of HIV Medicine | Vol 13, No 3 | a130 |
DOI: https://doi.org/10.4102/sajhivmed.v13i3.130
| © 2012 P Patel, M Brooks, G Anabwani, M A Tolle
| This work is licensed under CC Attribution 4.0
Submitted: 15 December 2012 | Published: 16 August 2012
Submitted: 15 December 2012 | Published: 16 August 2012
About the author(s)
P Patel, Botswana-Baylor Children’s Clinical Centre of Excellence, Princess Marina Hospital, Gaborone, BotswanaM Brooks, Botswana-Baylor Children’s Clinical Centre of Excellence, Princess Marina Hospital, Gaborone, Botswana, and Ohio University School of Medicine, Athens, Ohio, USA
G Anabwani, Botswana-Baylor Children’s Clinical Centre of Excellence, Princess Marina Hospital, Gaborone, Botswana
M A Tolle, Baylor College of Medicine Children’s Foundation, Bugando Medical Centre, Mwanza, Tanzania, and Department of Pediatrics, Retrovirology and Global Health Section, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, USA
Abstract
Elite and viraemic controllers represent unique subsets of HIV-infected patients who may also be long-term non-progressors (LTNPs). LNTPs constitute an estimated 1 - 15% of the total HIV-positive population in the USA and Europe, but less is known about their epidemiology in sub-Saharan Africa. Though the exact mechanisms for long-term non-progression appear to be numerous and are still under investigation, research on elite controllers may hold the key to new therapeutics and vaccine development. The clinical management of such patients can be challenging, as there are no standard guidelines for treatment, particularly in resource-limited settings. We describe the case of an HIV-infected Botswanan man who is likely an elite or viraemic controller.
Keywords
HIV; non-progression; Botswana
Metrics
Total abstract views: 3710Total article views: 6786